Creating materials for testing new influenza vaccines
Task V32: Manufacture of Influenza Virus Human Challenge Material for Phase I/II Clinical Testing
This study is all about creating and improving materials for new flu vaccines, so we can make better vaccines that help keep everyone healthier and prevent the flu.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11042053 on NIH RePORTER |
What this research studies
This research focuses on the manufacturing and characterization of materials needed for developing and testing new influenza vaccines. It involves planning and optimizing vaccine products, ensuring they meet regulatory standards, and producing them in compliance with good manufacturing practices for early clinical trials. Patients may benefit from this research as it aims to enhance the development of effective vaccines against influenza, which can lead to better prevention strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals at risk for influenza or those interested in vaccine development.
Not a fit: Patients who are not at risk for influenza or those who are not interested in vaccine participation may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective influenza vaccines, improving public health outcomes.
How similar studies have performed: Other research in vaccine development has shown success with similar approaches, indicating a promising path for this project.
Where this research is happening
New York, United States
- International AIDS Vaccine Initiative — New York, United States (Active)
Researchers
- Principal investigator: Sagar, Sangeetha — International AIDS Vaccine Initiative
- Study coordinator: Sagar, Sangeetha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.